BRPI0606871A2 - "processos e compostos para a preparação de derivados de naftilindol substituìdos - Google Patents

"processos e compostos para a preparação de derivados de naftilindol substituìdos

Info

Publication number
BRPI0606871A2
BRPI0606871A2 BRPI0606871-5A BRPI0606871A BRPI0606871A2 BR PI0606871 A2 BRPI0606871 A2 BR PI0606871A2 BR PI0606871 A BRPI0606871 A BR PI0606871A BR PI0606871 A2 BRPI0606871 A2 BR PI0606871A2
Authority
BR
Brazil
Prior art keywords
processes
preparation
substituted
compounds
derivatives
Prior art date
Application number
BRPI0606871-5A
Other languages
English (en)
Inventor
Vladimir A Dragan
John Richard Potoski
Wayne G Mcmahon
Xinxu Shi
Jean Louise Helom
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Corp filed Critical Wyeth Corp
Publication of BRPI0606871A2 publication Critical patent/BRPI0606871A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/004—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reaction with organometalhalides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/76—Ketones containing a keto group bound to a six-membered aromatic ring
    • C07C49/84—Ketones containing a keto group bound to a six-membered aromatic ring containing ether groups, groups, groups, or groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

PROCESSOS E COMPOSTOS PARA A PREPARAçãO DE DERIVADOS DE NAFTILINDOL SUBSTITUìDOS. A presente invenção refere-se a processos para a preparação de derivados de naftilindol substituidos de fórmula (1) que podem ser usados como inibidores de inibidor-1 de ativador de plasminogênio (PAI-1). Em certas modalidades da invenção, os processos envolvem reações que incluem uma ou mais de uma oxidação Oppenauer, uma síntese de indol Fisher, uma clivagem de metil éter ou acoplamento de um metil tetrazol substituído com um naftol substituído.
BRPI0606871-5A 2005-01-27 2006-01-25 "processos e compostos para a preparação de derivados de naftilindol substituìdos BRPI0606871A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US64761805P 2005-01-27 2005-01-27
PCT/US2006/002996 WO2006081455A1 (en) 2005-01-27 2006-01-25 Processes and compounds for the preparation of substituted naphthylindole derivatives

Publications (1)

Publication Number Publication Date
BRPI0606871A2 true BRPI0606871A2 (pt) 2009-07-21

Family

ID=36570379

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0606871-5A BRPI0606871A2 (pt) 2005-01-27 2006-01-25 "processos e compostos para a preparação de derivados de naftilindol substituìdos

Country Status (21)

Country Link
US (2) US7323483B2 (pt)
EP (1) EP1856104A1 (pt)
JP (1) JP2008528618A (pt)
KR (1) KR20070103744A (pt)
CN (1) CN101111491A (pt)
AR (1) AR053437A1 (pt)
AU (1) AU2006208021A1 (pt)
BR (1) BRPI0606871A2 (pt)
CA (1) CA2595376A1 (pt)
CR (1) CR9215A (pt)
GT (1) GT200600032A (pt)
HN (1) HN2006003347A (pt)
IL (1) IL183712A0 (pt)
MX (1) MX2007008952A (pt)
NI (1) NI200700188A (pt)
NO (1) NO20072879L (pt)
PE (1) PE20061200A1 (pt)
RU (1) RU2007121255A (pt)
TW (1) TW200637850A (pt)
WO (1) WO2006081455A1 (pt)
ZA (1) ZA200706203B (pt)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007092207A1 (en) * 2006-02-03 2007-08-16 Wyeth Compositions for the delivery of substituted naphthyl indole derivatives and methods of their use

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE903206A1 (en) 1989-09-07 1991-03-13 Abbott Lab Indole-, benzofuran-, and benzothiophene-containing¹lipoxygenase-inhibiting compounds
US5151435A (en) * 1991-04-08 1992-09-29 Merck & Co., Inc. Angiotensin ii antagonists incorporating an indole or dihydroindole
IL101785A0 (en) 1991-05-10 1992-12-30 Fujisawa Pharmaceutical Co Urea derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
IL109568A0 (en) 1993-05-19 1994-08-26 Fujisawa Pharmaceutical Co Urea derivatives, pharmaceutical compositions containing the same and processes for the preparation thereof
US6756388B1 (en) 1993-10-12 2004-06-29 Pfizer Inc. Benzothiophenes and related compounds as estrogen agonists
CA2134192A1 (en) 1993-11-12 1995-05-13 Michael L. Denney 5, 6-bicyclic glycoprotein iib/iiia antagonists
US5552412A (en) 1995-01-09 1996-09-03 Pfizer Inc 5-substitued-6-cyclic-5,6,7,8-tetrahydronaphthalen2-ol compounds which are useful for treating osteoporosis
IL120724A0 (en) 1995-09-01 1997-08-14 Lilly Co Eli Indolyl neuropeptide Y receptor antagonists
JP2000516958A (ja) 1996-08-26 2000-12-19 ジェネティックス・インスチチュート・インコーポレーテッド ホスホリパーゼ酵素の阻害剤
US6703527B2 (en) * 2001-05-24 2004-03-09 Nikken Chemicals Co., Ltd. Method for oxidation of allyl alcohol
TWI224101B (en) * 2001-06-20 2004-11-21 Wyeth Corp Substituted naphthyl indole derivatives as inhibitors of plasminogen activator inhibitor type-1 (PAI-1)
TW591020B (en) 2001-06-20 2004-06-11 Wyeth Corp 6-(aryl-amido or aryl-amidomethyl)-naphthalen-2-yloxy-acidic derivatives as inhibitors of plasminogen activator inhibitor type-1 (PAI-1)

Also Published As

Publication number Publication date
AR053437A1 (es) 2007-05-09
NI200700188A (es) 2008-05-09
RU2007121255A (ru) 2009-03-10
TW200637850A (en) 2006-11-01
US20080071091A1 (en) 2008-03-20
KR20070103744A (ko) 2007-10-24
MX2007008952A (es) 2007-09-18
GT200600032A (es) 2006-11-14
CR9215A (es) 2007-11-23
CA2595376A1 (en) 2006-08-03
WO2006081455A1 (en) 2006-08-03
IL183712A0 (en) 2007-09-20
AU2006208021A1 (en) 2006-08-03
HN2006003347A (es) 2011-03-30
CN101111491A (zh) 2008-01-23
EP1856104A1 (en) 2007-11-21
NO20072879L (no) 2007-06-26
PE20061200A1 (es) 2006-12-19
JP2008528618A (ja) 2008-07-31
US7323483B2 (en) 2008-01-29
US20060183917A1 (en) 2006-08-17
ZA200706203B (en) 2009-12-30

Similar Documents

Publication Publication Date Title
SG163585A1 (en) Melanocortin receptor ligands
BRPI0719393B8 (pt) composição farmacêutica
MY148634A (en) Pyridazinone derivatives
CL2008001017A1 (es) Compuestos derivados de indol, activadores de glucoquinasa; composicion farmaceutica que los comprende; y su uso para la prevencion o el tratamiento de diabetes u obesidad.
MA29799B1 (fr) Administration d'inhibiteurs de dipeptidyl peptidase
BRPI0713349A2 (pt) Inibidores de proteína tirosina fosfatase humana e métodos de utilização
UY31736A (es) Derivados sustituidos de pirazol y su uso
MA31151B1 (fr) Inhibiteurs de mapk/erk kinase
MX2009009540A (es) Inhibidores de metaloproteasa que contienen una porcion heterociclica.
CR11618A (es) Inhibidores macrocíclicos de serina proteasa
TNSN08373A1 (en) Azolopyrimidines as inhibitors of cannabinoid 1 activity
BRPI0606379A2 (pt) triazolftalazinas
BR0210720A (pt) Composto e uso do mesmo
BRPI0621446C1 (pt) composição farmacêutica para uso externo
MA32150B1 (fr) Inhibiteurs heterocycliques de la stearoyl-coa desaturase
ECSP067110A (es) Derivados de 2-carbamida-4-feniltiazol, su preparación y su aplicación en terapéutica
MY146671A (en) Tetrahydronaphthaline derivatives, methods for the production and use thereof as anti-inflammatory agents
ECSP10010379A (es) Derivados de oxindol sustituido y su uso para el tratamiento de enfermedades dependientes de la vasopresina
UY30356A1 (es) Derivados de 3-halo-n-(2.(4-fluorofenil)-4-oxobutil)-n-metil-5-(trifluorometil)benzamida y composiciones de los mismos.
TW200631947A (en) Crystal forms of 2-(3-fluoro-4-hydroxyphenyl)-7-vinyl-1, 3-benzoxazol-5-ol
DE602006014305D1 (de) Pyrroloä2,3-büpyridinderivate als modulatoren des h3-rezeptors
ATE491764T1 (de) Auto-adhäsiver klebstoff
TR201109686T2 (tr) Olmesartan'ın Farmasötik Bileşimleri.
BRPI0606871A2 (pt) "processos e compostos para a preparação de derivados de naftilindol substituìdos
ATE452130T1 (de) 1-(hetero)aryl-3-aminopyrrolidinderivate zur verwendung als antagonisten des mglur3-rezeptors

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 3A E 6A ANUIDADE(S).

B08J Incorrect entry in the gazette republished [chapter 8.10 patent gazette]

Free format text: REFERENTE A DESPACHO 8.6 NA RPI 2161 DE 05/06/2012. TEXTO CORRETO: REFERENTE A 6A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO NAO CUMPRIMENTO DESPACHO 8.6 NA RPI 2161 DE 05/06/2012, E DO DESPACHO 8.10 NA RPI 2164 DE 26/06/2012